LRP5 and osteoporosis-pseudoglioma syndrome: Studies have shown that inactivating mutations of LRP5 gene can decrease the activity of osteoblasts, resulting in osteoporosis pseudoglioma syndrome (OPPG), an autosomal recessive disorder characterized by extremely low bone mass (Joiner et al. 2013).